Home > News > British company leads the way following a £4 million injection of funds
April 20th, 2004
British company leads the way following a £4 million injection of funds
Oxonica Limited, a major player in the exciting new area of applied nanomaterials has successfully raised £4 million ($7M US) in its latest round of investment. Dr Kevin Matthews, Oxonica's CEO, commented on the fundraising: "Oxonica has supportive investors who recognise that the Company has established itself with substantial and near term commercial opportunities. The funds were raised from both Institutional and Individual shareholders. The investment money raised in 2002 has been successfully deployed in developing products and securing pathfinder revenues."
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015